3 completed, 1 terminated, 1 unknown. 1 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 4 | 1 | Terminated 1 |
Follow AORTICA Group: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cardiac COVID-19 Health Care Workers Passed infection of SARS-CoV-2 - SARS-CoV 2, COVID-19 | Completed | AORTICA Group | 142 | 2020-05-25 | 2020-06-16 | |
| Prasugrel vs. Ticagrelor on Myocardial Injury in STEMI Prasugrel, Ticagrelor - ST Elevation Myocardial Infarction | Not applicable | Completed | AORTICA Group | 61 | 2015-11-23 | 2019-06-10 |
| The SALMANTICOR Study Structural Heart Abnormality | Completed | AORTICA Group | 2057 | 2015-10-15 | 2019-06-10 | |
| Cardiotoxicity in the Elderly Imaging studies - Cardiotoxicity, Elderly | Unknown | AORTICA Group | 110 | 2015-03-01 | 2020-05-27 | |
| Randomized Study to Evaluate the Efficacy of Fluvastatin on Inflammatory Markers in Patients With Aortic Stenosis. Fluvastatin - Aortic Valve Stenosis | Phase 4 | Terminated | AORTICA Group | 164 | 2006-10-01 | 2019-06-07 |
Aortic Valve Stenosis (1) · COVID-19 (1) · Cardiotoxicity (1) · Coronavirus Infections (1) · Disease Progression (1) · Heart Defects, Congenital (1) · Inflammation (1) · Motor Activity (1) · Myocarditis (1) · ST Elevation Myocardial Infarction (1)
Fluvastatin (1) · Prasugrel Hydrochloride (1) · Ticagrelor (1)
Spain (5)
Pedro L Sanchez, MD, PhD (2) · Candido Martin-Luengo, MD, PhD (1)